Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey Liu

Showing results (261-270 of 574) with videos related to

Pageof 58
Sort By:
Clinical Trials (London, England)|January 3, 2020
Trial marketing in the Pan-Canadian Early Detection of Lung Cancer StudyJanice L Rudkowski, Gregory R Pond, Alain Tremblay, et al.
Plos One|August 29, 2020
Nicotine dependence as a risk factor for upper aerodigestive tract (UADT) cancers: A mediation analysisSera Thomas, June C Carroll, M Catherine Brown, et al.
Disease Models & Mechanisms|September 3, 2025
Immunological dynamics in orthotopic versus subcutaneous murine models of HPV-positive oropharyngeal cancerMinzi Mao, Ke Qiu, Lan Feng, et al.
Cancer|July 1, 2020
Measuring financial toxicity incurred after treatment of head and neck cancer: Development and validation of the Financial Index of Toxicity questionnaireKatrina Hueniken, Catriona M Douglas, Ashok R Jethwa, et al.
Chest|March 5, 2021
Risk Perception Among a Lung Cancer Screening PopulationJane Turner, Gregory R Pond, Alain Tremblay, et al.
Lung Cancer (Amsterdam, Netherlands)|August 10, 2018
The prognostic effect of single and multiple cancer-related somatic mutations in resected non-small-cell lung cancerKevin Jao, Pascale Tomasini, Suzanne Kamel-Reid, et al.
Oncotarget|October 21, 2017
A phase I study of foretinib plus erlotinib in patients with previously treated advanced non-small cell lung cancer: Canadian cancer trials group IND.196Natasha B Leighl, Ming-Sound Tsao, Geoffrey Liu, et al.
Cancers|July 24, 2019
Somatic Alteration Burden Involving Non-Cancer Genes Predicts Prognosis in Early-Stage Non-Small Cell Lung CancerDennis Wang, Nhu-An Pham, Timothy M Freeman, et al.
Pharmacogenetics and Genomics|June 10, 2014
Cancer patients acceptance, understanding, and willingness-to-pay for pharmacogenomic testingSinead Cuffe, Henrique Hon, Xin Qiu, et al.
BMJ Open|March 21, 2025
Retrospective cohort study assessing clinical outcomes of patients with extensive-stage small cell lung cancer treated with and without consolidative thoracic radiotherapy at the Princess Margaret Cancer CentreVijithan Sugumar, Rohan Salunkhe, Hadee Lone, et al.
Pageof 58

Showing results (261-270 of 574) with videos related to

Sort By:
Pageof 58
Clinical Trials (London, England)|January 3, 2020
Trial marketing in the Pan-Canadian Early Detection of Lung Cancer StudyJanice L Rudkowski, Gregory R Pond, Alain Tremblay, et al.
Plos One|August 29, 2020
Nicotine dependence as a risk factor for upper aerodigestive tract (UADT) cancers: A mediation analysisSera Thomas, June C Carroll, M Catherine Brown, et al.
Disease Models & Mechanisms|September 3, 2025
Immunological dynamics in orthotopic versus subcutaneous murine models of HPV-positive oropharyngeal cancerMinzi Mao, Ke Qiu, Lan Feng, et al.
Cancer|July 1, 2020
Measuring financial toxicity incurred after treatment of head and neck cancer: Development and validation of the Financial Index of Toxicity questionnaireKatrina Hueniken, Catriona M Douglas, Ashok R Jethwa, et al.
Chest|March 5, 2021
Risk Perception Among a Lung Cancer Screening PopulationJane Turner, Gregory R Pond, Alain Tremblay, et al.
Lung Cancer (Amsterdam, Netherlands)|August 10, 2018
The prognostic effect of single and multiple cancer-related somatic mutations in resected non-small-cell lung cancerKevin Jao, Pascale Tomasini, Suzanne Kamel-Reid, et al.
Oncotarget|October 21, 2017
A phase I study of foretinib plus erlotinib in patients with previously treated advanced non-small cell lung cancer: Canadian cancer trials group IND.196Natasha B Leighl, Ming-Sound Tsao, Geoffrey Liu, et al.
Cancers|July 24, 2019
Somatic Alteration Burden Involving Non-Cancer Genes Predicts Prognosis in Early-Stage Non-Small Cell Lung CancerDennis Wang, Nhu-An Pham, Timothy M Freeman, et al.
Pharmacogenetics and Genomics|June 10, 2014
Cancer patients acceptance, understanding, and willingness-to-pay for pharmacogenomic testingSinead Cuffe, Henrique Hon, Xin Qiu, et al.
BMJ Open|March 21, 2025
Retrospective cohort study assessing clinical outcomes of patients with extensive-stage small cell lung cancer treated with and without consolidative thoracic radiotherapy at the Princess Margaret Cancer CentreVijithan Sugumar, Rohan Salunkhe, Hadee Lone, et al.
Pageof 58